NRIX logo
NRIX NASDAQ US

Nurix Therapeutics, Inc. - Common stock

Healthcare · Biotechnology Website · IPO Jul 2020
$15.51
▲ +$0.03 (+0.19%)
Vol 1.2M
4
Quality Score
fail
Mkt Cap
$1.9B
ROE
-53.6%
Margin
-292.5%
D/E
0.00
Beta
1.96
52W
$8–$22

Wall Street Consensus

23 analysts · Apr 2026
8
Strong Buy
14
Buy
1
Hold
0
Sell
0
Strong Sell
95.7%
Buy Rating

Price Chart

Similar Stocks

PVLA
Palvella Therapeutics Inc
$1.2B
ZYME
Zymeworks Inc
$2.0B
ANAB
AnaptysBio Inc
$1.3B
RXRX
Recursion Pharmaceuticals Inc
$2.1B
NTLA
Intellia Therapeutics Inc
$1.0B
ARDX
Ardelyx Inc
$1.4B
VIR
Vir Biotechnology Inc
$838.9M

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.89 $-0.82 +$0.07
Sep 2025 $-0.86 $-1.03 $-0.17
Jun 2025 $-0.74 $-0.52 +$0.22
Mar 2025 $-0.78 $-0.67 +$0.11

Fundamentals Trend

Metric 2025-08-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -53.6% -45.3% -45.3% -53.6% -53.6% -53.6%
P/E (TTM) — — — — — —
Net Margin -1094.8% -234.6% -234.6% -292.5% -292.5% -292.5%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.35 6.82 6.82 5.35 5.35 5.35

Key Ratios

ROA (TTM)
-40.8%
P/S (TTM)
22.98
P/B
3.0
EPS (TTM)
$-2.97
CF/Share
$-2.61
Rev Growth 3Y
+22.4%
52W High
$22.50
52W Low
$8.18
$8.18 52-Week Range $22.50

How does NRIX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

NRIX AAPG ABEO ABOS ABP

NRIX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
23.0
▲ 79% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
3.0
▲ 21% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

NRIX profitability vs Biotechnology peers

ROE
-53.6%
▲ 20% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-292.5%
▼ 2% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-40.8%
▲ 13% above peers (-46.7%)
vs Peers
vs Industry
In line

NRIX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.4
▲ 21% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
2.0
▲ 102% above peers (1.0)
vs Peers
vs Industry
More volatile

NRIX fundamentals radar

NRIX Peer median Industry

NRIX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NRIX vs peers: key metrics

Latest News

No related news yet